Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Techniques for Saturation Prostate Biopsy
NCT02909049Phase 4Completed
- Sponsor
- Complejo Hospitalario Universitario de A Coruña
- Start
- Apr 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mepivacaine in prostate cancer (PCa) (2 arms), sponsored by Complejo Hospitalario Universitario de A Coruña. Primary endpoint: Visual Analog Scale at 1 hour. Started Apr 2016; status: completed.
02
Drugs
mepivacaine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02909049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909049.